SAKAR — Sakar Healthcare Income Statement
0.000.00%
- IN₹7.63bn
- IN₹8.49bn
- IN₹1.78bn
- 86
- 16
- 85
- 71
Annual income statement for Sakar Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 947 | 1,282 | 1,334 | 1,534 | 1,776 |
Cost of Revenue | |||||
Gross Profit | 436 | 509 | 574 | 657 | 953 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 802 | 1,085 | 1,152 | 1,330 | 1,488 |
Operating Profit | 145 | 197 | 182 | 203 | 287 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 132 | 190 | 169 | 159 | 215 |
Provision for Income Taxes | |||||
Net Income After Taxes | 107 | 152 | 128 | 117 | 175 |
Net Income Before Extraordinary Items | |||||
Net Income | 107 | 152 | 128 | 117 | 175 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 107 | 152 | 128 | 117 | 175 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.09 | 9.96 | 6.75 | 5.69 | 7.97 |